Format

Send to

Choose Destination
See comment in PubMed Commons below
J Fam Plann Reprod Health Care. 2002 Jul;28(3):135-6.

Atrophic vulvovaginitis in women aged 50 years and above, both current and non-users of hormone replacement therapy, attending a genitourinary medicine clinic.

Author information

1
Department of Genitourinary Medicine, St Mary's Hospital, Portsmouth PO3 6AD, UK.

Abstract

INTRODUCTION:

In women aged 50 years and over attending a genitourinary medicine (GUM) department the commonest presentation was with symptoms of vulval soreness, irritation or dryness. Atrophic vulvovaginitis (AVV) was the commonest diagnosis made. This study was undertaken to determine if the presence of AVV was related to the use, or not, of systemic hormone replacement therapy (HRT).

METHOD:

A prospective study was made of all women aged 50 years and over attending a GUM department over a 3-month period.

RESULTS:

Of the 124 women seen in this age group, 60 (40%) had AVV and 28 (23%) had vaginal candidiasis. No difference was found in current users or non-users of HRT.

CONCLUSION:

Accurate diagnosis is essential in women with vulval symptoms to ensure that appropriate therapy is given. In the present study symptomatic women aged 50 years and over were more likely to have AVV than candidiasis irrespective of their use of systemic HRT.

PMID:
16259830
DOI:
10.1783/147118902101196261
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center